ClinicaSpace Focus
   Monday, December 01, 2008 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
TOP SPONSOR

Advancing Oncology. Changing Medicine. Crown Bioscience Inc. is a US-based oncology service company committed to advancing anti-cancer therapeutics through the preclinical and drug development stages. Our multi-disciplinary team of experts, located in two research campuses in Beijing and Shanghai, provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. Crown Bio offers a full range of predictive models; such as HuPrime(TM) xenografts, OmniPanel(TM) cell based screens, and SnapShot(TM) translational research services to provide data to help you select the development candidate with the highest chance of success.

To learn more about our unique portfolio and breadth of services, visit: http://www.crownbio.com
HeadHtml
•  FDA Approves Duramed Pharmaceuticals, Inc. (BRL)'s Synthetic Conjugated Estrogens-A Vaginal Cream More...
•  Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S. More...
•  IMPAX Laboratories, Inc. (IPXL) Receives Final FDA Approval for Generic Wellbutrin(R) XL 150 mg More...

More Drug Approval News
HeadHtml
•  Spectrum Pharmaceuticals, Inc. (SPPI) Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009 More...

More PDUFA News
HeadHtml
•  Eli Lilly and Company (LLY) (JOBS) Pulls FDA Application for Cymbalta for Pain More...
•  AstraZeneca PLC (AZN) Infant Lung Drug Faces U.S. Delay More...
•  Sanofi-Aventis (France) (SASY.PA)'s Multaq to get U.S. Panel Review in March More...
•  FDA Accepts Cell Therapeutics, Inc. (CTIC)'s Zevalin sBLA and Grants Priority Review May Accelerate First-line Launch by Four Months More...
•  Biovail Corporation (BVF) Announces Filing of ANDA for Quetiapine XR Tablets More...

More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Sunesis Pharmaceuticals, Inc. (SNSS) Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at American Society of Hematology More...
•  TorreyPines Therapeutics, Inc. (TPTX)'s NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects More...
•  GeoVax Labs Inc. (GOVX.OB)'s Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America More...
•  Genaera Corporation (GENR) Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics More...
•  Enobia Pharma Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease More...

More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
HeadHtml
•  National Cancer Institute: Variations In Gene Activity Can Predict The Survival Of Patients With Lymphoma More...
•  Melatonin May Save Eyesight In Inflammatory Disease, The University of Buenos Aires and The National Research Council (CONICET) Study Suggests More...
•  Choosing Local Or General Anaesthetic For Carotid Surgery - Study Shows No Difference In Outcome (Gala Trial), The Lancet, Leeds General Infirmary Study More...
•  Transfusing Anemic Cancer Patients Boosts Clot Risk, University of Rochester Study More...
•  Diamyd Medical AB: Diamyd(R) Diabetes Vaccine - Three Blockbuster Indications More...

More General Clinical Research News
Latest Market Insight
The Future of RNAi Therapeutics: Drug Pipelines and Prospects

• Analyze emerging RNAi agents and delivery technologies and examine new molecular targets and pipeline antisense drugs.
• Evaluate 97 RNAi compounds in development for infectious and inflammatory diseases, cancer and other major disease categories.
• Assess 37 competitors and potential collaborators developing RNAi technologies and examine the latest RNAi-related patenting trends.
• Identify potential growth segments and develop future strategies with this report's forecasts for the global RNAi therapy market to 2012.

Click Here for More Information
DIA
Top Jobs
BioMidwest (St. Louis, Missouri) Hot Job of the Day:

KV Pharmaceutical
Clinical Study Manager
The successful candidate will direct and/or coordinate clinical research programs designed to support the Company's effort to obtain approved New Drug applications and Abbreviated New Drug Applications for various therapeutic entities.

Biotech Beach (Los Angeles, California) Hot Job of the Day:

Core Logic, Inc.
Regulatory Writer, Regulatory Affairs and Quality Assurance
The Regulatory Writer will assist in the production of regulatory (i.e., non-clinical, CMC, clinical) documentation required by regulatory agencies for IND/CTA and NDA/MAA submissions.

BioMidwest (Ames, Iowa) Hot Job of the Day:

NewLink Genetics
Clinical Data Manager
Duties include: Work with consultants and IT personnel to validate and implement Clintrial, and set up studies, Coordinate CRF development with the Director of Clinical Affairs, etc.

Biotech Bay (Fremont, California) Hot Job of the Day:

Boston Scientific Corporation
Clinical Line Manager
Will provide regional management to assigned staff members in the Clinical organization. Through collaboration with clinical core team members, ensures clinical programs are carried out to a standard consistent with regulatory, corporate and clinical policies/procedures.

Genetown (Cambridge, Massachusetts) Hot Job of the Day:

MedFocus LLC
Clinical Data Specialist
The Clinical Data Specialist II is an individual contributor performing complex data management tasks independently. The Clinical Data Specialist II plays a key role on moderately complex studies. In addition, the Clinical Data Specialist II manages external vendors on assigned studies.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!

January 28, 2009 Biotech Bay Career Fair

BioSpace and DeviceSpace are joining forces to present the Biotech Bay Career Fair on Wednesday, January 28, 2009 at the South San Francisco Conference Center in South San Francisco, CA.

The Biotech Bay Career Fair will provide unlimited opportunities to individuals in the pharmaceutical, biotech, medical device and diagnostics fields. Qualified job seekers and top companies in the industry can come together in one convenient location to interview for hundreds of open positions.

Do not miss the chance to interview with the biopharmaceutical industry's most prestigious companies!

Click Here TO SUBMIT YOUR RESUME FOR THE BIOTECH BAY CAREER FAIR NOW!

Qualified candidates will receive their invitations and confirmation numbers via email 24 to 48 hours after their resumes have been submitted. Pre-screened and accepted candidates must bring a copy of their invitation with confirmation number to the event.

We look forward to seeing you at the Biotech Bay Career Fair!

Biotech Bay Career Fair, January 28, 2009
Pharm Country Career Fair, February 2, 2009
CALAsia La Jolla Career Fair, February 23, 2009

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services

HeadHtml
•  Barr Pharmaceuticals, Inc. (BRL) Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg More...
•  Mylan Inc. Confirms First-to-File Patent Challenge Relating to AMRIX(R) More...
•  Bradmer Pharmaceuticals Inc. Issued Patent in Europe for Use of Neuradiab(TM) to Treat Lymphoma More...
•  Geron Corporation (GERN) Issues Statement Regarding European Patent Office Decision in Wisconsin Alumni Research Foundation (WARF) Patent Appeal More...
•  Redpoint Bio Corporation (RPBC) Receives Two U.S. Patents Covering Compositions and Methods for Low-Sodium Salt Substitute More...

More Patent News
Events
Cell & Gene Therapy Forum 2009 and Washington Vaccine Forum 2009

January 26 - 28, 2009
Washington D.C.

Web Site: www.phacilitate.co.uk

Phacilitate's Cell & Gene Therapy Forum and Washington Vaccine Forum take place together for the 4th time in 2009. Phacilitate Vaccine Forums are the essential annual events for senior level decision-makers involved in the rapid, cost-effective development and commercialization of safe new prophylactic and therapeutic vaccines. The Phacilitate Cell & Gene Therapy Forum is a unique event – the first and only meeting to address the strategic business requirements of senior decision-makers from the global cell, tissue and gene therapy sectors as they progress towards the commercialization of safe and effective treatments. The two conferences take place in parallel with all networking activites shared. 500+ senior level life sciences executives attended in 2008.

Please visit www.phacilitate.co.uk, e-mail team@phacilitate.co.uk, or call +44 (0)20 7839 6137.
Feature

Hot Company



Illumina, Inc.
9885 Towne Centre Drive
San Diego, California 92121-1975 U.S.A.
Phone: 858-202-4500 Fax: 858-202-4545
View Jobs

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible.

More Company Profiles
Contact Us
Send questions and comments to the ClinicaSpace NewsBeat Team East Coast Office:
    ClinicaSpace
    Ramshorn Executive Centre
    2399 Highway 34, Building A-5
    Manasquan, New Jersey 08736-1528 U.S.A.
    Phone: 732-528-3688
    Fax: 732-528-3668
West Coast Office:
    ClinicaSpace
    90 New Montgomery Street, Suite 414
    San Francisco, California 94105 U.S.A.
    Phone: 877-277-7585
    Fax: 415-576-9217
Editor & Publisher:
    Rosemary Do
Editorial & Production Staff:
    Annalyn Aquino
    Suvarna Bhatt
    Lana Ho
    Matt Thwin
BioSpace.com - Life * Science * Community
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2008 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the ClinicaSpace Focus here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here or by clicking on the "unsubscribe" link at the bottom of this newsletter.